‘Rawalpindi Express’ hopes India will visit Pakistan for Champions Trophy 2025
- 8
- 0
RAWALPINDI: In a recent interview with a local TV channel, former fast bowler and renowned cricketer Shoaib Akhtar, also known as the “Rawalpindi Express,” expressed his belief that back-channel negotiations between Pakistan and India will eventually lead to India’s participation in the Champions Trophy, despite the current uncertainties.
Akhtar emphasized the importance of not losing hope and waiting for a solution. Akhtar pointed out the crucial role of India in the global cricket ecosystem, stating, “We all know that 95 to 96 percent of sponsorship in the International Cricket Council (ICC) comes from India, which is why the Indian board can exert pressure.” He added that the situation was not solely in the hands of the Pakistan Cricket Board (PCB) or the Board of Control for Cricket in India (BCCI) but ultimately depended on the governments of both countries. He also raised a hypothetical scenario, saying,
“Imagine Virat Kohli playing in Pakistan and scoring a century. While Pakistan cannot host major events like the World Cup, the Champions Trophy could be a significant step towards such larger tournaments. I still believe the Indian team will come to Pakistan.” The comments come amidst ongoing verbal disputes between the cricket boards of India and Pakistan over the logistics of the Champions Trophy. Additionally, broadcasting companies have begun to put pressure on the ICC to announce the tournament schedule, citing financial losses caused by the delays. ICC officials are also reportedly concerned about the lack of flexibility shown by both cricket boards. If the Indian board continues to hold a rigid stance, it could result in substantial financial losses for the ICC. Meanwhile, Pakistan has firmly rejected the hybrid model for the Champions Trophy, reiterating its position to the ICC. Pakistan, the defending champions of the tournament, won the 2017 final by defeating India by 180 runs under the captaincy of Sarfaraz Ahmed.